PFM
WST icon

Premier Fund Managers’s West Pharmaceutical WST Stock Holding History

Premier Fund Managers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Hold
906
– – 0.03% 135
2026
Q1 		$222K Buy
+906
New +$225K 0.02% 142

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Premier Fund Managers's WST Position: Q2 2026 in Review

Premier Fund Managers held its West Pharmaceutical (WST) position steady in Q2 2026 at 906 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #135.

Premier Fund Managers first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Premier Fund Managers held 906 shares of West Pharmaceutical worth $321K as of Q2 2026.
  • Premier Fund Managers left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.03% of Premier Fund Managers's portfolio in Q2 2026, its #135 holding.
  • Premier Fund Managers first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.